Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause International normalised ratio fluctuation? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of International normalised ratio fluctuation have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.

7
Reports of International normalised ratio fluctuation with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
0
Deaths
1
Hospitalizations

How Dangerous Is International normalised ratio fluctuation From TREPROSTINIL?

Of the 7 reports, 1 (14.3%) required hospitalization.

Is International normalised ratio fluctuation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause International normalised ratio fluctuation?

WARFARIN (738) ADALIMUMAB (167) METHOTREXATE (159) BISOPROLOL (155) LEFLUNOMIDE (150) CELECOXIB (149) LEVOFLOXACIN (149) NORFLOXACIN (149) PREDNISONE (149) CEFACLOR (148)

Which TREPROSTINIL Alternatives Have Lower International normalised ratio fluctuation Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All International normalised ratio fluctuation Reports All Drugs Causing International normalised ratio fluctuation TREPROSTINIL Demographics